Creative Planning
COLL icon

Creative Planning’s Collegium Pharmaceutical COLL Stock Holding History

Creative Planning’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.5M Buy
41,341
+11,703
+39% +$400K ﹤0.01% 2324
2026
Q1 		$980K Buy
29,638
+3,174
+12% +$134K ﹤0.01% 2480
2025
Q4 		$1.23M Buy
26,464
+1,286
+5% +$53.8K ﹤0.01% 2120
2025
Q3 		$881K Buy
25,178
+2,520
+11% +$87.6K ﹤0.01% 2222
2025
Q2 		$670K Buy
22,658
+10,307
+83% +$294K ﹤0.01% 2206
2025
Q1 		$369K Sell
12,351
-509
-4% -$15.6K ﹤0.01% 2572
2024
Q4 		$368K Buy
12,860
+5,530
+75% +$183K ﹤0.01% 2503
2024
Q3 		$283K Buy
7,330
+166
+2% +$5.92K ﹤0.01% 2562
2024
Q2 		$231K Buy
7,164
+1,792
+33% +$62.1K ﹤0.01% 2577
2024
Q1 		$209K Buy
+5,372
New +$188K ﹤0.01% 2538
2019
Q4 		– Sell
-17,335
Closed -$199K – 2021
2019
Q3 		$199K Buy
+17,335
New +$198K ﹤0.01% 1610

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Creative Planning's COLL Position: Q2 2026 in Review

Creative Planning increased its Collegium Pharmaceutical (COLL) stake by 39% in Q2 2026, buying an estimated $400K and bringing the position to 41,341 shares worth $1.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2324.

Creative Planning first reported a position in COLL in Q3 2019 and has held it in 11 quarters since. 280 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Creative Planning held 41,341 shares of Collegium Pharmaceutical worth $1.5M as of Q2 2026.
  • Creative Planning bought 11,703 Collegium Pharmaceutical shares in Q2 2026, an estimated $400K.
  • Collegium Pharmaceutical made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #2324 holding.
  • Creative Planning first reported a position in Collegium Pharmaceutical in Q3 2019 and has held it in 11 quarters since.
  • 280 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.